Clinical Trial Results:
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral
Suberoylanilide Hydroxamic Acid (L-001079038) in Patients With Advanced Malignant
Pleural Mesothelioma Previously Treated With Systemic Chemotherapy
Summary
|
|
EudraCT number |
2005-000949-11 |
Trial protocol |
SE GB DE BE PT IT GR ES |
Global completion date |
21 Nov 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1 |
This version publication date |
20 May 2016
|
First version publication date |
20 May 2016
|
Other versions |
v2 |
Summary report(s) |
redacted synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.